1 |
Bourdin A, Dotta-Celio J, Niquille A, Berger J. Response to the first wave of the COVID-19 pandemic in the community pharmacy of a University Center for Primary Care and Public Health. Res Social Adm Pharm 2022;18(4):2706-10.
DOI
|
2 |
Cerbin-Koczorowska M, Waszyk-Nowaczyk M. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland. Int J Environ Res Public health 2020;17(18):6659.
DOI
|
3 |
Crowley D, Delargy I. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report. Harm Reduct J 2020;17(1):49.
DOI
|
4 |
Daskalakis G, Cid A, Grindrod K, Beazely MA. Investigating community pharmacy take home naloxone dispensing during COVID-19: The impact of one public health crisis on another. Pharmacy 2021;9(3):129.
DOI
|
5 |
Giua C, Paoletti G, Minerba L, et al. Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists. Int J Clin Pharm 2021;43(3):708-15.
DOI
|
6 |
Gregory PAM, Austin Z. COVID-19: How did community pharmacies get through the first wave? Can Pharm J (Ott) 2020;153(5):243-51.
DOI
|
7 |
Imlach F, McKinlay E, Kennedy J, et al. E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand. BMC Fam Pract 2021;22(1):140.
DOI
|
8 |
Klepser NS, Klepser DG, Adams JL, Adams AJ, Klepser ME. Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities. Res Social Adm Pharm 2021;17(9):1574-8.
DOI
|
9 |
Koster ES, Philbert D, Bouvy ML. Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Social Adm Pharm 2021;17(1):2002-4.
DOI
|
10 |
Lim RH, Shalhoub R, Sridharan BK. The experiences of the community pharmacy team in supporting people with dementia and family carers with medication management during the COVID-19 pandemic. Res Social Adm Pharm 2021;17(1):1825-31.
DOI
|
11 |
Lin CH, Lin YW, Wang JY, Lin MH. The pharmaceutical practice of mask distribution by pharmacists in Taiwan's community pharmacies under the Mask Real-Name System, in response to the COVID-19 outbreak. Cost Eff Resour Alloc 2020;18:45.
DOI
|
12 |
Lin YW, Lin CH, Lin MH. Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan. Cost Eff Resour Alloc 2021;19(1):76.
DOI
|
13 |
Lubi K, Sepp K, Rass H, Roostar K, Volmer D. A qualitative study of the challenges in rearranging community pharmacy service provision during the COVID-19 public health emergency: The prism of social practice theory. Public Health Pract (Oxf) 2021;2:100212.
DOI
|
14 |
Mamiya KT, Yoshida A. Changes in Japanese pharmacists' recognition of their role in community public health before and after the spread of COVID-19. Pharmacy (Basel) 2021;9(3):154.
DOI
|
15 |
Manouchehri M, Bhamra SK, Fernandez-Alfonso MS, Gil-Ortega M. The real impact of COVID-19 on community pharmacy professionals as part of the primary health care frontier workforce in Spain. J Pharm Pharmacogn Res 2021;9(6):878-91.
DOI
|
16 |
Molas ME, Knobel H, Ferrandez O, et al. Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment. Rev Esp Quimioter 2022;35(1):71-5.
DOI
|
17 |
Okuyan B, Bektay MY, Kingir ZB, Save D, Sancar M. Community pharmacy cognitive services during the COVID-19 pandemic: A descriptive study of practices, precautions taken, perceived enablers and barriers and burnout. Int J Clin Pract 2021;75(12):e14834.
|
18 |
Stampfli D, Martinez-De la Torre A, Simi E, Du Pasquier S, Berger J, Burden AM. Community pharmacist-administered covid-19 vaccinations: A pilot customer survey on satisfaction and motivation to get vaccinated. Vaccines (Basel) 2021;9(11):1320.
DOI
|
19 |
Patel J, Christofferson N, Goodlet KJ. Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey. J Am Pharm Assoc 2022;62(1):187-93.
DOI
|
20 |
Pelaez Bejarano A, Villar Santos P, Robustillo-Cortes MLA, Sanchez Gomez E, Santos Rubio MD. Implementation of a novel home delivery service during pandemic. Eur J Hosp Pharm 2021;28(Suppl 2):e120-e123.
DOI
|
21 |
Stoa MK, Frail CK, Farley JF, Pestka DL, Blanchard CM. Adaptations made to delivery of comprehensive medication management in the community pharmacy setting during COVID-19. Explor Res Clin Soc Pharm 2021;4:100089.
|
22 |
Toth JM, Rosenthal M, Sharma M, Barnard M. Caregivers' Perspectives of Pharmacist Intervention in Children's Antibiotic Prescriptions for Upper Respiratory Tract Infections. J Pharm Pract 2021:8971900211033459.
|
23 |
Zaidi STR, Hasan SS. Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm 2021;17(1):1832-7.
DOI
|
24 |
Zimmermann A, Placzek J, Wrzosek N, Owczarek A. Assessment of pharmacists prescribing practices in Poland-A descriptive study. Healthcare (Basel) 2021;9(11):1505.
|
25 |
Zozaya N, Gonzalez-Dominguez A, Calvente N, et al. Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: A pilot experience in times of COVID-19 in Spain. Glob Reg Health Technol Assess 2021;8(1):8-13.
|
26 |
Henderson C, Knapp M, Fernandez JL, et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ 2013;346:f1035.
DOI
|
27 |
Jordan D, Guiu-Segura JM, Sousa-Pinto G, Wang LN. How COVID-19 has impacted the role of pharmacists around the world. Farm Hosp 2021;45(2):89-95.
|
28 |
Rezahi S, Mathers A, Patel P, Tilli T, Dolovich L. Telehealth in community pharmacy: A new "place" for the appointment-based model given COVID-19 and the future of health care. Can Pharm J (Ott) 2021;154(6):363-7.
DOI
|
29 |
Littauer SL, Dixon DL, Mishra VK, Sisson EM, Salgado TM. Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review. Pharm Pract (Granada) 2017;15(4):1134.
DOI
|
30 |
Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review. Res Social Adm Pharm 2018;14(8):707-17.
DOI
|
31 |
Lee J. Investigation review of Ministry of Health and Welfare, 'special pharmacy for drug delivery'. MedicalTimes, 2022. Available from https://www.medicaltimes.com/Main/News/NewsView.html?ID=1148541&ref=daum. Accessed August 18, 2022.
|
32 |
Hess K, Bach A, Won K, Seed SM. Community pharmacists roles during the COVID-19 pandemic. J Pharm Pract 2022;35(3):469-76.
DOI
|
33 |
Kang H. "Discussion of institutionalization for non face-to-face service, issues of electronic prescription and drug delivery". DailyPharm, 2022. Available from http://www.dailypharm.com/Users/News/NewsView.html?ID=288550&REFERER=DM. Accessed August 18, 2022.
|
34 |
Smith AC, Thomas E, Snoswell CL, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare 2020;26(5):309-13.
DOI
|
35 |
Maidment I, Young E, MacPhee M, et al. Rapid realist review of the role of community pharmacy in the public health response to COVID-19. BMJ open 2021;11(6):e050043.
DOI
|
36 |
Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health 2020;74(11):964-8.
|
37 |
Cohen MA, Tavares J. Who are the most at-risk older adults in the COVID-19 era? It's not just those in nursing homes. J Aging Soc Policy 2020;32(4-5):380-6.
DOI
|
38 |
Beland D, Marier P. COVID-19 and long-term care policy for older people in Canada. J Aging Soc Policy 2020;32(4-5):358-64.
DOI
|
39 |
Shinan-Altman S, Levkovich I. Healthcare utilization among breast cancer patients during the COVID-19 outbreak. Palliat Support Care 2020;18(4):385-91.
DOI
|
40 |
Kirby A, Drummond FJ, Lawlor A, Murphy A. Counting the social, psychological, and economic costs of COVID-19 for cancer patients. Support Care Cancer 2022;30(11):8705-31.
DOI
|
41 |
Latif A, Faull C, Waring J, et al. Managing medicines at the end of life: a position paper for health policy and practice. J Health Organ Manag 2021;35(9):368-77.
DOI
|
42 |
Austin Z, Gregory P. Resilience in the time of pandemic: The experience of community pharmacists during COVID-19. Res Social Adm Pharm 2021;17(1):1867-75.
DOI
|
43 |
Park H. Seoul Pharmaceutical Association opens a forum for infectious diseases and the role of pharmacists and pharmacies. Kyunghyang Shinmun, 2022. Available from https://news.v. daum.net/v/20220509143132209. Accessed August 18, 2022.
|
44 |
Park K, Byeon J, Yang Y, Cho H. Healthcare utilisation for elderly people at the onset of the COVID-19 pandemic in South Korea. BMC Geriatr 2022;22(1):395.
DOI
|
45 |
Wasilewski MB, Szigeti Z, Sheppard CL, et al. Infection prevention and control across the continuum of COVID-19 care: A qualitative study of patients', caregivers' and providers' experiences. Health Expect 2022;25(5):2431-9.
DOI
|
46 |
World Health Organization. Declaration of Astana. Astana, Kazakhstan: World Health Organization, 2018. Available from https://www.who.int/docs/default-source/primary-health/declaration/gcphc-declaration.pdf. Accessed July 27, 2022.
|
47 |
International Pharmaceutical Federation. FIP Community Pharmacy Section. Vision 2020-2025: Pharmacists at the heart of our communities. 2020. Available from www.fip.org/files/CPS_vision_FINAL.pdf. Accessed July 27, 2022.
|
48 |
Iacobucci G. Covid-19: all non-urgent elective surgery is suspended for at least three months in England. BMJ 2020;368:m1106.
DOI
|
49 |
Rimmer A. Covid-19: GPs can stop health checks for over 75s and routine medicine reviews. BMJ 2020;368:m1157.
DOI
|
50 |
Ahn S, Kim S, Koh K. Associations of the COVID-19 pandemic with older individuals' healthcare utilization and self-reported health status: a longitudinal analysis from Singapore. BMC Health Serv Res 2022;22(1):66.
DOI
|
51 |
Dopfer C, Wetzke M, Zychlinsky Scharff A, et al. COVID-19 related reduction in pediatric emergency healthcare utilization - a concerning trend. BMC Pediatr 2020;20(1):427.
DOI
|
52 |
Birkmeyer JD, Barnato A, Birkmeyer N, Bessler R, Skinner J. The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Aff 2020;39(11):2010-7.
DOI
|
53 |
Lantelme P, Couray Targe S, Metral P, et al. Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic. Arch Cardiovasc Dis 2020;113(6-7):443-7.
DOI
|
54 |
Mehrotra A, Chernew ME, Linetsky D, Hatch H, Cutler DA, Schneider EC. The Impact of COVID-19 on Outpatient Visits in 2020: Visits Remained Stable, Despite a Late Surge in Cases. New York: The Commonwealth Fund, 2021. Available from https://www.commonwealthfund.org/publications/2021/feb/impact-covid19-outpatient-visits-2020-visits-stable-despite-late-surge. Accessed July 29, 2022.
|
55 |
Lam W, Mey A, King MA, Woods P. The nature of conflict in community pharmacy - A pilot study of pharmacists' experiences during the COVID-19 pandemic. Res Social Adm Pharm 2022;18(7):3164-73.
DOI
|
56 |
Kone A, Horter L, Rose C, et al. The impact of traumatic experiences, coping mechanisms, and workplace benefits on the mental health of U.S. public health workers during the COVID-19 pandemic. Ann Epidemiol 2022;74:66-74.
DOI
|
57 |
Sheehan KA, Schulz-Quach C, Ruttan LA, et al. "Don't just study our distress, do something": Implementing and evaluating a modified stepped-care model for health care worker mental health during the COVID-19 pandemic. Can J Psychiatry 2023;68(1):43-53.
DOI
|
58 |
Sayarshad HR. Personal protective equipment market coordination using subsidy. Sustain Cities Soc 2022;85:104044.
DOI
|
59 |
Park M, Shin Y. "What should I do? All cold medicine is out of stock" Pharmacies are at war. Kookmin Ilbo, 2022. Available from https://news.v.daum.net/v/20220321000401247. Accessed August 18, 2022.
|
60 |
Jo J. <'Corona 19' Super Emergency> The app saying 'Masks in stock,' but actually "None" at pharmacy. Munhwa Ilbo, 2020. Available from https://news.v.daum.net/v/20200311120049173. Accessed August 18, 2022.
|
61 |
Cadogan CA, Hughes CM. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis. Res Social Adm Pharm 2021;17(1):2032-5.
DOI
|
62 |
El Hadidi S, Sabra K. What we learnt after looking back at the community pharmacists' experiences worldwide in COVID-19 pandemic. J Pharm Pract 2021:8971900211036093.
|
63 |
Jeong M. [COVID-19] KPA, supply the same quantity and uniform price of masks to pharmacies nationwide. Financial News, 2020. Available from https://news.v.daum.net/v/20200303060029946. Accessed August 18, 2022.
|
64 |
Oh NS, Yoo W-K, Lee I-H. Perception on necessity to introduce public out-of-hours pharmacies and operation plan: A Gyeongsangbukdo case. Korean J Clin Pharm 2022;32(2):93-105.
DOI
|
65 |
Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 2018;169(7):467-73.
DOI
|
66 |
Amariles P, Ledezma-Morales M, Salazar-Ospina A, Hincapie-Garcia JA. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Social Adm Pharm 2021;17(1):1988-9.
DOI
|
67 |
Baratta F, Ciccolella M, Brusa P. The relationship between customers and community pharmacies during the covid-19 (Sarscov-2) pandemic: A survey from Italy. Int J Environ Res Public health 2021;18(18):9582.
DOI
|